Obesity Cancer

New obesity drugs such as Novo Nordisk A/S's Wegovy and Eli Lilly & Co.'s Zepbound could be an $80 billion market by 2030

The new research integrates animal studies, clinical trials, and public health data to help explain rising cancer rates

These cells were found in greater number in obese prostate cancer and obese breast cancer patients